Source: Citybizlist

Pharmascience: Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Announce Exit from Pharmaceutics International

NEW YORK-(BUSINESS WIRE)-A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today... Read MoreThe post Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Announce Exit from Pharmaceutics International appeared first on citybiz.

Read full article »

Pharmascience's Competitors | Pharmascience's News | Pharmascience's Financials

Followers on Owler

271

Est. Annual Revenue

$500M-1.0B

Est. Employees

1.0-5.0K

CEO

Martin Arès

CEO Approval Rating

82/100

Pharmascience is a Canada-based pharmaceutical company that develops and commercializes generic drugs and over-the-counter products for the healthcare industry.